Metronidazole does not have major food restrictions, but taking the tablets with food can lessen stomach upset. Alcohol should be avoided during treatment and for at least 48 hours after the final dose to prevent a disulfiram-like reaction.
While metronidazole possesses antibacterial activity, it is not approved for acne treatment. Dermatologists may use other topical agents (e.g., clindamycin) for acne management.
The drug’s half-life is roughly 8 hours in healthy adults, so it is usually eliminated within 2-3 days after the last dose. Impaired liver function can extend clearance time.
Yes, but keep the medication in its original packaging with the prescription label visible. Bring a copy of the prescription or a doctor’s note in case security asks for verification.
UK-marketed 200 mg tablets often bear the imprint “200 MG” and the manufacturer’s logo; 400 mg tablets may show “400 MG” with a similar logo. Exact markings can vary by manufacturer.
No over-the-counter drug has the same anaerobic and protozoal coverage as metronidazole. Prescription therapy is required for the infections it treats.
Standard alcohol breath or urine tests detect ethanol, not its metabolites. However, a disulfiram-like reaction may mimic intoxication symptoms without changing test results.
The metallic taste results from the drug’s interaction with taste receptors in the oral cavity; it is a common, transient side effect.
Both are nitro-imidazole antibiotics, but tinidazole has a longer half-life, allowing once-daily dosing for many infections. Metronidazole is more widely available in the UK and has a broader range of approved indications.
As a generic agent, metronidazole’s price is set by market competition among manufacturers. Generic tablets are typically less expensive than branded equivalents, with price variations based on dosage strength and pharmacy procurement contracts.
Metronidazole is an antibacterial and antiprotozoal agent classified as an antibiotic. It is supplied in oral pill form at strengths of 200 mg and 400 mg. In the United Kingdom, metronidazole is a prescription-only medicine (POM) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). The drug is used to treat a variety of bacterial and protozoal infections, particularly those caused by anaerobic organisms.
Metronidazole enters microbial cells by passive diffusion. Inside anaerobic bacteria and susceptible protozoa, it is reduced by ferredoxin-type proteins to form reactive nitro-radical intermediates. These radicals damage DNA, inhibit nucleic acid synthesis, and lead to cell death. Because the reduction step requires a low-oxygen environment, metronidazole is selective for anaerobes and certain protozoa, sparing most aerobic human cells.
Metronidazole is approved by the MHRA for the following indications:
These uses reflect the drug’s activity against obligate anaerobes and certain protozoa.
Evidence from peer-reviewed studies supports several off-label uses, although they are not formally approved by the MHRA:
Off-label use requires medical supervision and individualized risk assessment.
If specific interaction data for a concomitant drug are unavailable, patients should disclose all medications, supplements, and herbal products to their healthcare provider.
Standard dosing:
200 mg tablets: Often prescribed 200 mg three times daily for certain infections (e.g., trichomoniasis).
400 mg tablets: Common regimens include 400 mg twice daily (e.g., bacterial vaginosis, intra-abdominal infections) or 400 mg three times daily for severe infections such as C. difficile colitis.
Duration of therapy: Typically 5-7 days for uncomplicated infections; up to 14 days or longer for deep-seated or chronic infections.
Special populations:
Renal or hepatic impairment: The prescribing clinician may reduce the dose or extend the dosing interval based on laboratory values.
Elderly: Monitor for neurotoxicity and adjust dose if severe organ dysfunction is present.
Administration tips: Swallow tablets whole with a full glass of water. Do not crush or chew unless directed by a pharmacist.
Missed dose: Take the missed dose as soon as remembered unless it is near the time of the next scheduled dose; do not double the dose.
Overdose: Symptoms may include nausea, vomiting, abdominal pain, and central nervous system depression. Seek emergency medical care; activated charcoal may be administered if presentation is early. No specific antidote exists.
Discontinuation: For short courses, abrupt cessation is acceptable. For prolonged therapy, especially when treating severe infections, a gradual taper is sometimes recommended to reduce the risk of seizure recurrence.
This article provides educational information about metronidazole and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
